SNIBE(SZ:300832) Xin Lang Zheng Quan·2025-12-23 05:35Core Viewpoint - The company, New Industry Biomedical Engineering Co., Ltd., has experienced a decline in stock price and financial performance, with a notable drop in net profit despite a slight increase in revenue [1][2]. Financial Performance - As of September 30, 2025, New Industry reported a revenue of 3.428 billion yuan, representing a year-on-year growth of 0.39% [2]. - The net profit attributable to shareholders was 1.205 billion yuan, showing a decrease of 12.92% compared to the previous period [2]. - The company's stock price has decreased by 17.04% year-to-date, with a 2.53% drop over the last five trading days and a 14.67% decline over the past 60 days [1]. Shareholder Information - The number of shareholders as of September 30, 2025, was 13,100, a decrease of 15.87% from the previous period [2]. - The average number of circulating shares per shareholder increased by 18.87% to 51,997 shares [2]. Dividend Distribution - Since its A-share listing, New Industry has distributed a total of 3.86 billion yuan in dividends, with 2.357 billion yuan distributed over the last three years [3]. Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the fourth-largest circulating shareholder, holding 26.4824 million shares, an increase of 4.2383 million shares from the previous period [3]. - The top ten circulating shareholders include various ETFs, with some increasing and others decreasing their holdings [3].